BUN/Creatinine-forhold forklart: Forstå resultatene av nyrefunksjonstesten din
Omfattende veiledning til blodprøver for BUN/Creatinine-ratio, hva farlige nivåer betyr, og hvordan Kantesti sin AI kan tolke resultatene dine for nyrefunksjon umiddelbart
Hva er BUN/Creatinine-ratio?
Hvis du nylig har fått svar på blodprøven og la merke til begrepet BUN/kreatinin-ratio eller lurte på hva BUN creatinine-ratio betyr, er du ikke alene. BUN/creatinine-ratio er en avgjørende måling som hjelper helsepersonell med å vurdere nyrefunksjon og identifisere mulige underliggende helsetilstander. Som Chief Medical Officer i Kantesti AI, møter jeg ofte pasienter som ønsker å forstå hva BUN- og kreatininverdiene deres betyr for den generelle nyrehelsen.
Hva måler BUN?
Blood Urea Nitrogen (BUN) måler mengden nitrogen i blodet ditt som kommer fra avfallsproduktet urea. Når kroppen din bryter ned proteiner fra mat og muskelmetabolisme, dannes urea i leveren som et biprodukt. Denne ureaen transporteres deretter via blodet til nyrene, der friske nyrer filtrerer den ut og skiller den ut gjennom urinen. En reduksjon i BUN-nivåer kan tyde på leverproblemer, underernæring eller overhydrering, mens forhøyede nivåer ofte tyder på nedsatt nyrefunksjon, dehydrering eller høyt proteininntak.
Hva måler kreatinin?
Kreatinin er et avfallsprodukt som dannes ved normal nedbrytning av kreatinfosfat i muskelvev. I motsetning til BUN er produksjonen av kreatinin relativt konstant basert på muskelmassen din, noe som gjør det til en mer stabil indikator på nyrefunksjon. Friske nyrer filtrerer effektivt kreatinin fra blodet og skiller det ut i urinen. Forhøyede nivåer av kreatinin i serum indikerer vanligvis redusert filtreringskapasitet i nyrene, noe som kan skyldes akutt nyreskade, kronisk nyresykdom eller dehydrering. Vår omfattende biomarkørveiledning gir detaljerte referanseområder for disse markørene.
Få svar på nyrefunksjonen din tolket umiddelbart
Last opp blodprøven din til Kantesti sin AI-analyzer for omfattende tolkning av BUN/kreatinin.
Analyze My Blood Test Free →⚠️ Viktig medisinsk ansvarsfraskrivelse
Informasjonen i denne artikkelen er kun ment for undervisningsformål og skal ikke erstatte profesjonell medisinsk rådgivning. Selv om innholdet vårt er gjennomgått av vår Medisinsk rådgivende styre, inkludert styresertifiserte leger og nefrologer, bør du alltid rådføre deg med kvalifiserte helsepersonell for diagnostikk og behandlingsvalg basert på dine individuelle forhold.
Normale vs. unormale BUN/kreatinin-forhold
Forstå hva BUN/kreatinin-forhold betyr krever at du vet hva som regnes som normale og unormale verdier. BUN/kreatinin-forholdet beregnes ved å dele BUN-verdien på kreatininverdien. Dette forholdet hjelper leger med å skille mellom ulike årsaker til forhøyede nivåer av BUN eller kreatinin. I henhold til kliniske retningslinjer fra National Kidney Foundation, ligger det normale BUN/kreatinin-forholdet typisk i området 10:1 til 20:1 hos friske voksne.
📊 Hurtigreferanse for BUN/kreatinin-forhold
Forhold: 10:1 til 20:1
BUN: 7–20 mg/dL
Kreatinin: 0,7–1,3 mg/dL (menn)
Kreatinin: 0,6–1,1 mg/dL (kvinner)
Høyt forhold (>20:1): Dehydrering, GI-blødning
Lavt forhold (<10:1): Leversykdom, underernæring
Begge forhøyet: Nyresvikt
Context matters for interpretation
What Causes High BUN/Creatinine Ratio?
When the BUN/kreatinin-ratio exceeds 20:1, it typically indicates conditions that increase BUN disproportionately to creatinine. Dehydration is the most common cause, as reduced blood volume concentrates BUN while creatinine remains relatively stable. Gastrointestinal bleeding elevates BUN because blood proteins are digested and absorbed in the intestines. High protein diets, catabolic states from illness or surgery, heart failure, and certain medications like corticosteroids can also raise the ratio. These conditions are often called "prerenal" causes because they affect the ratio before blood reaches the kidneys.
What Causes Low BUN/Creatinine Ratio?
A low BUN/creatinine ratio below 10:1 typically suggests conditions that reduce BUN production or increase creatinine. Severe liver disease impairs urea synthesis, resulting in lower BUN levels despite normal kidney function. Malnutrition or inadequate protein intake also decreases BUN production. Conditions that increase creatinine, such as rhabdomyolysis (muscle breakdown) or high muscle mass relative to body size, can lower the ratio. Certain medications and pregnancy can also affect the ratio through various mechanisms.
Dangerously High BUN/Creatinine: When to Worry
Understanding what is a dangerously high BUN/creatinine ratio is essential for recognizing when to seek immediate medical attention. While mild elevations often reflect benign causes like dehydration, significant abnormalities can indicate serious underlying conditions that require prompt evaluation and treatment.
Critical BUN and Creatinine Levels
A BUN level above 100 mg/dL is considered severely elevated and often indicates acute kidney injury, end-stage renal disease, or severe prerenal azotemia. Creatinine levels above 4.0 mg/dL typically reflect significant kidney impairment with a glomerular filtration rate (GFR) below 15-20 mL/min. When both values are markedly elevated, the ratio becomes less meaningful than the absolute values themselves, as this pattern strongly suggests intrinsic kidney disease. Our clinically validated AI algorithms flag these critical values for immediate attention.
Kidney Disease Indicators
Chronic kidney disease (CKD) progresses through five stages based on GFR, with rising creatinine and BUN accompanying each stage. Early kidney disease (stages 1-2) may show only mildly elevated creatinine with normal BUN/creatinine ratio. As kidney function declines (stages 3-5), both markers increase, and the ratio often normalizes between 10:1 and 15:1 because both waste products accumulate proportionally. The eGFR calculated from creatinine provides a more accurate assessment of kidney function than either marker alone.
The Dehydration Connection
Dehydration is one of the most common causes of elevated BUN/creatinine ratio. When fluid intake is inadequate or fluid loss is excessive (from vomiting, diarrhea, excessive sweating, or diuretic use), blood becomes more concentrated. This affects BUN more than creatinine because BUN reabsorption in the kidneys increases during dehydration. A ratio above 20:1, especially above 30:1, strongly suggests dehydration or another prerenal cause. The good news is that dehydration-related elevations typically resolve rapidly with proper fluid replacement.
📋 Seek Medical Attention If You Experience:
- BUN levels above 50 mg/dL with symptoms
- Creatinine levels above 2.5 mg/dL on repeat testing
- BUN/Creatinine ratio above 30:1 with dehydration signs
- Decreased urine output or dark-colored urine
- Persistent nausea, fatigue, or confusion
- Swelling in legs, ankles, or around eyes
- Persistent high blood pressure
- Blood in urine or foamy urine
Creatine Kinase (CPK): Related Muscle & Heart Marker
While BUN and creatinine primarily reflect kidney function, creatine kinase (CPK), also known as creatine phosphokinase, is a separate but related biomarker found in muscle tissue, including the heart and skeletal muscles. Understanding creatine kinase CPK normal range values is important because CPK elevation can affect creatinine levels and provide additional diagnostic information.
CPK Normal Ranges
Det creatine kinase CPK normal range varies based on sex, age, muscle mass, and laboratory methodology. Generally, normal CPK values range from 22 to 198 units per liter (U/L) in adults, with males typically having higher values than females due to greater muscle mass. Athletes and individuals with high muscle mass may have baseline CPK levels 1.5 to 2 times the standard upper limit. CPK is also measured as three isoenzymes: CK-MM (skeletal muscle), CK-MB (cardiac muscle), and CK-BB (brain tissue), each providing specific diagnostic information.
Muscle Damage Indicators
Elevated CPK primarily indicates muscle injury or damage. Common causes include intense physical exercise, muscle trauma, intramuscular injections, seizures, and rhabdomyolysis. Rhabdomyolysis, a severe condition involving rapid muscle breakdown, can cause CPK to rise 50 to 100 times normal levels and release myoglobin that damages the kidneys. This connection between CPK and kidney function explains why severe muscle damage can temporarily elevate creatinine levels and impair kidney function.
Heart Attack Connection
The CK-MB isoenzyme is particularly important for diagnosing myocardial infarction (heart attack). When heart muscle cells are damaged due to blocked coronary arteries, they release CK-MB into the bloodstream. CK-MB levels typically rise within 3-6 hours after a heart attack, peak at 12-24 hours, and return to normal within 48-72 hours. However, troponin tests have largely replaced CK-MB as the preferred cardiac biomarker due to their higher specificity and longer detection window. Learn more about cardiac markers in our biomarkørreferanseguide.
BNP Levels: Heart Failure Marker
B-type Natriuretic Peptide (BNP) and its related marker NT-proBNP are important biomarkers that connect heart function to kidney health. Understanding what is a dangerous BNP level is crucial because heart failure and kidney disease frequently coexist and worsen each other in a condition called cardiorenal syndrome.
What is a Dangerous BNP Level?
BNP levels below 100 pg/mL generally rule out heart failure, while levels above 400 pg/mL strongly suggest heart failure is present. Values between 100-400 pg/mL fall into a gray zone requiring clinical correlation. According to guidelines from the American Heart Association, BNP levels above 500 pg/mL indicate significant cardiac stress and warrant prompt evaluation. Levels exceeding 1000 pg/mL often correlate with severe heart failure and carry serious prognostic implications.
Connection to Kidney Function
Forholdet mellom BNP og nyrefunksjon er toveis. Hjertesvikt reduserer hjertets minuttvolum, noe som senker blodstrømmen til nyrene og svekker deres evne til å filtrere avfallsstoffer som BUN og kreatinin. Denne "framoversvikten" øker renale biomarkører. Omvendt svekker nyresykdom BNP-clearance, noe som fører til forhøyede BNP-nivåer selv uten hjertesvikt. Denne overlappen betyr at pasienter med forhøyet BUN, kreatinin og BNP bør vurderes for både hjerte- og nyrelidelser. Vår AI-blodprøveanalysator tar hensyn til disse komplekse sammenhengene når vi tolker resultater.
📋 Veiledning for tolkning av BNP
Bruk av AI for analyse av nyrefunksjon
Moderne teknologi har endret måten vi tolker komplekse nyrefunksjonstester på. Hos Kantesti, bruker vår avanserte AI-blodprøveanalysator et proprietært proprietært nevralt nettverk som er spesielt utviklet for tolkning av biomarkører. I motsetning til generiske AI-systemer er plattformen vår bygget fra grunnen av for medisinsk diagnostikk, og den er validert av vår Medisinsk rådgivende styre for å oppnå 98.7% klinisk nøyaktighet.
Umiddelbare resultater
Få en omfattende tolkning av nyrefunksjonen din på under 60 sekunder, tilgjengelig 24/7
98.7% Accuracy
Klinisk validerte AI-algoritmer trent på millioner av resultater fra nyrepaneler
75+-språk
Forstå resultatene dine for nyrefunksjon på ditt eget språk
Trendanalyse
Følg endringene i BUN, kreatinin og eGFR over tid med funksjoner for historisk sammenligning
Vårt AI-system er spesielt effektivt til å identifisere subtile mønstre i markører for nyrefunksjon som kan tyde på tilstander i tidlig fase før de blir klinisk tydelige. For eksempel kan en gradvis økende kreatinintrend over flere tester tyde på utviklende nyredysfunksjon, selv før verdiene overstiger det normale området. Denne evnen til tidlig oppdagelse gir brukerne mulighet til å iverksette proaktive helsetiltak i samråd med helsepersonellet sitt. Du kan lære mer om vår kliniske valideringsprosess og metodikk på vår side med casestudier.
🔬 Ready to Understand Your Kidney Function Results?
Upload your blood test to Kantesti's AI-powered analyzer and receive instant, physician-reviewed interpretation of your BUN, creatinine, eGFR, and complete metabolic panel.
Frequently Asked Questions About BUN/Creatinine Ratio
Hva er et farlig høyt BUN/kreatinin-forhold?
A BUN/creatinine ratio above 20:1 is considered elevated, but a ratio exceeding 30:1 is more concerning and often indicates significant dehydration, gastrointestinal bleeding, or heart failure. However, the clinical significance depends on the absolute values as well. If both BUN and creatinine are severely elevated (BUN >100 mg/dL, creatinine >4.0 mg/dL), the ratio becomes less meaningful than the individual values, which suggest serious kidney dysfunction requiring immediate medical attention.
Hva betyr BUN/Creatinine-forholdet for nyrehelsen?
The BUN/creatinine ratio helps physicians differentiate between prerenal causes (affecting the ratio before blood reaches the kidneys) and intrinsic kidney disease. A high ratio (>20:1) typically suggests dehydration, high protein intake, or gastrointestinal bleeding—conditions that elevate BUN more than creatinine. A normal ratio (10:1 to 20:1) with elevated absolute values suggests intrinsic kidney disease where both markers rise proportionally. A low ratio (<10:1) may indicate liver disease, malnutrition, or conditions that specifically elevate creatinine.
Hva forårsaker en reduksjon i BUN-nivåer?
A decrease in BUN levels can result from several conditions. Severe liver disease impairs the liver's ability to convert ammonia to urea, reducing BUN production. Malnutrition or very low protein diets decrease the protein available for metabolism. Overhydration dilutes blood components including BUN. Pregnancy increases blood volume and kidney filtration, lowering BUN. Syndrome of inappropriate antidiuretic hormone (SIADH) causes excessive water retention. Certain medications and genetic conditions affecting the urea cycle can also reduce BUN levels.
Hva er det normale området for kreatinkinase CPK?
The creatine kinase (CPK) normal range typically falls between 22 to 198 U/L for adults, though values vary by laboratory. Males generally have higher values (39-308 U/L) than females (26-192 U/L) due to greater muscle mass. Athletes and highly muscular individuals may have baseline CPK levels 1.5-2 times the standard upper limit. CPK has three isoenzymes: CK-MM (skeletal muscle), CK-MB (cardiac muscle), and CK-BB (brain), each with specific diagnostic significance. Elevated total CPK can indicate muscle injury, heart attack, or rhabdomyolysis.
Kan kunstig intelligens tolke nøyaktig resultatene av BUN/kreatinin-forholdet?
Yes, advanced AI systems like Kantesti's proprietary neural network can accurately interpret BUN/creatinine ratio results. AI blood test analyzers evaluate BUN and creatinine alongside other metabolic panel markers, electrolytes, and patient demographics to identify patterns and potential health concerns. Our system is CE marked and has been validated by board-certified nephrologists on our Medical Advisory Board, providing comprehensive kidney function insights that complement professional medical consultation.
Hvordan påvirker dehydrering nivåene av BUN og kreatinin?
Dehydration affects BUN more significantly than creatinine, causing the BUN/creatinine ratio to increase above 20:1. When fluid intake is inadequate, blood becomes concentrated and kidney blood flow decreases. The kidneys respond by increasing urea (BUN) reabsorption to conserve water, but creatinine remains relatively stable because it is not significantly reabsorbed. This differential effect makes an elevated ratio a useful marker for dehydration. With proper rehydration, BUN levels typically normalize quickly, usually within 24-48 hours.
What does a low BUN/creatinine ratio mean?
A low ratio is usually interpreted alongside the actual BUN, creatinine, eGFR, and liver tests. It can happen with low protein intake, overhydration, pregnancy, or liver disease, so your clinician may repeat the test or check related labs.
Can a normal BUN/creatinine ratio still miss kidney disease?
Yes. Some people with early kidney disease have a normal ratio, especially if BUN and creatinine rise together or kidney damage is mainly detected through urine protein. That is why eGFR and a urine albumin-to-creatinine ratio are often checked alongside blood tests.
Why would my BUN/creatinine ratio be high if my eGFR is still normal?
That pattern often means something temporary is affecting BUN more than creatinine, such as dehydration, a high-protein intake, recent illness, or certain medicines. If you feel well and your creatinine and eGFR are stable, your clinician may simply review the context and recheck the test.
Should I stop creatine or protein shakes before a BUN/creatinine test?
Creatine supplements, a large meat-heavy meal, and very hard workouts in the day before testing can shift BUN or creatinine and make the ratio harder to interpret. Tell your clinician about supplements, and avoid unusually intense exercise and protein loading for 24 hours unless you were told otherwise.
References
- Jager KJ, Kovesdy C, Langham R, et al. A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases. Nyre Int. 2019;96(5):1048-1050. doi:10.1016/j.kint.2019.07.012
- GBD-samarbeidet om kronisk nyresykdom. Global, regional og nasjonal sykdomsbyrde ved kronisk nyresykdom, 1990–2017: en systematisk analyse for Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-733. doi:10.1016/S0140-6736(20)30045-3
- Levey AS, Coresh J. Kronisk nyresykdom. Lancet. 2012;379(9811):165-180. doi:10.1016/S0140-6736(11)60178-5
- Morgan DB, Carver ME, Payne RB. Plasmakreatinin og urea: kreatinin-/urea-ratio i pasienter med forhøyet plasmatisk urea. Br Med J. 1977;2(6092):929-932. doi:10.1136/bmj.2.6092.929
- Hosten AO. BUN og kreatinin. I: Walker HK, Hall WD, Hurst JW, red. Kliniske metoder: Historie, fysisk undersøkelse og laboratorieundersøkelser. 3. utg. Boston: Butterworths; 1990. NCBI Bookshelf
- Kellum JA, Lameire N. Diagnostikk, vurdering og behandling av akutt nyreskade: en KDIGO-oppsummering. Crit Care. 2013;17(1):204. doi:10.1186/cc11454
- Bello AK, Levin A, Lunney M, et al. Global Kidney Health Atlas: en rapport fra International Society of Nephrology om den globale sykdomsbyrden av nyresykdom i sluttstadiet og kapasitet for nyreerstatningsterapi og konservativ behandling på tvers av land og regioner i verden. Int Soc Nephrol. 2019. ISN Atlas
- Ene-Iordache B, Perico N, Bikbov B, et al. Kronisk nyresykdom og kardiovaskulær risiko i seks regioner i verden (ISN-KDDC): en tverrsnittsstudie. Lancet Glob Health. 2016;4(5):e307-319. doi:10.1016/S2214-109X(16)00071-1
- Topol EJ. Høyytelsesmedisin: sammenløpet av menneskelig og kunstig intelligens. Nat Med. 2019;25(1):44-56. doi:10.1038/s41591-018-0300-7
- Esteva A, Kuprel B, Novoa RA, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542(7639):115-118. doi:10.1038/nature21056
- Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019;380(14):1347-1358. doi:10.1056/NEJMra1814259
- Yu KH, Beam AL, Kohane IS. Artificial intelligence in healthcare. Nat Biomed Eng. 2018;2(10):719-731. doi:10.1038/s41551-018-0305-z
- Kantesti AI. Clinical Validation and Regulatory Compliance Documentation. Technical Report. Munich: Kantesti AI; 2025. Available at: https://kantesti.net/medical-validation/
- Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737-1749. doi:10.1056/NEJMoa2102953
- Vaswani A, Shazeer N, Parmar N, et al. Attention is all you need. Advances in Neural Information Processing Systems. 2017;30. NeurIPS
- KDIGO. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Nyre Int. 2024;105(4S):S117-S314. KDIGO Guidelines
- Clinical and Laboratory Standards Institute (CLSI). Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory. CLSI Guideline EP28-A3c. Wayne, PA: CLSI; 2010. CLSI
- National Kidney Foundation. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266. NKF Guidelines
- Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174. doi:10.2307/2529310
- Vassalotti JA, Centor R, Turner BJ, et al. Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician. Am J Med. 2016;129(2):153-162.e7. doi:10.1016/j.amjmed.2015.08.025
- Inker LA, Astor BC, Fox CH, et al. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD. Am J Kidney Dis. 2014;63(5):713-735. doi:10.1053/j.ajkd.2014.01.416
- Zhang Y, Liu M, Chen L, et al. Machine learning-based prediction of kidney function from routine laboratory tests. J Am Med Inform Assoc. 2023;30(4):721-730. doi:10.1093/jamia/ocac245
- Chen T, Wang X, Zhou H, et al. Ensemble deep learning for automated chronic kidney disease staging using multi-parameter laboratory data. Artif Intell Med. 2024;147:102735. doi:10.1016/j.artmed.2023.102735
- Wiens J, Shenoy ES. Machine Learning for Healthcare: On the Verge of a Major Shift in Healthcare Epidemiology. Clin Infect Dis. 2018;66(1):149-153. doi:10.1093/cid/cix731
Get Your Complete Kidney Function Analysis Today
Join over 2 million users who trust Kantesti AI for accurate blood test interpretation. Upload your metabolic panel results and receive instant insights into your BUN, creatinine, eGFR, and 127+ other biomarkers.
Supporting Clinical Research
This educational guide is supported by peer-reviewed research validating AI-powered kidney function interpretation across 1.2 million blood test results.
Klein T, Weber H, Mitchell S. Clinical Validation of AI-Powered BUN/Creatinine Ratio and Kidney Function Interpretation: A Multi-Parameter Neural Network Approach for Enhanced Renal Diagnostic Accuracy. J AI Clin Med. 2026;8(1):1-12.
How to Cite This Article:
Klein T, Weber H, Mitchell S. Clinical Validation of AI-Powered BUN/Creatinine Ratio and Kidney Function Interpretation: A Multi-Parameter Neural Network Approach for Enhanced Renal Diagnostic Accuracy. J AI Clin Med. 2026;8(1):1-12. doi:10.5281/zenodo.18207872
Medical Disclaimer
Important Information About This Educational Content
Educational Content - Not Medical Advice
This article about BUN/Creatinine ratio and kidney function tests is intended for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Always consult with qualified healthcare professionals, particularly nephrologists, before making any medical decisions based on blood test results. The information provided has been reviewed by our Medical Advisory Board but should not replace professional medical consultation.
For Informational Purposes Only
This article provides general information about BUN, creatinine, kidney function markers, and related biomarkers. Individual health decisions should always be made in consultation with licensed healthcare providers who can consider your complete medical history and current health status.
Consult Healthcare Professionals
If you have concerns about your BUN/creatinine ratio or any other kidney function parameters, please consult with a qualified physician, nephrologist, or other licensed healthcare provider. Do not delay seeking professional medical advice based on information in this article.
Why Trust This Content
This guide meets Google's highest E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness) standards for medical content
Experience
Based on real-world analysis of 2M+ blood tests from users across 127+-land with validated clinical outcomes
- 1.2 million kidney function interpretations
- 98.7% clinical accuracy rate
- Continuous learning from patient outcomes
Expertise
Written by Dr. Thomas Klein, MD (CMO) and reviewed by 12 board-certified physicians on our Medical Advisory Board
- Lead: Thomas Klein, MD - 15+ years nephrology
- Co-Author: Prof. Dr. Hans Weber - Laboratory Medicine
- Reviewer: Dr. Sarah Mitchell, MD, PhD - Clinical Pathology
Authoritativeness
Recognized by global technology leaders and validated through peer-reviewed research in clinical journals
- Microsoft for Startups Founders Hub Partner
- NVIDIA Inception Program Member
- Google Cloud Healthcare-partner
- Published in J AI Clin Med (DOI: 10.5281/zenodo.18207872)
Trustworthiness
Full regulatory compliance with transparent methodology og 24 peer-reviewed citations
- CE Marked Medical Device (EU MDR 2017/745)
- HIPAA Compliant (US Healthcare Data)
- GDPR Compliant (EU Data Protection)
- ISO 27001 informasjonssikkerhet